@article{ref1,
title="Wrong study window to assess the full impacts of legalization on pediatric cannabis exposures",
journal="Pediatrics",
year="2022",
author="Myran, Daniel and Finkelstein, Yaron",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="Topics: cannabis, exposure, marijuana  We thank Yeung and colleagues for an important contribution to the literature on harms and potential health effects to young children and older adolescents after legalization of recreational, or nonmedical, cannabis in Canada.1   We are writing to highlight an important clarification to the regulatory policies under study, to help readers contextualize the observations in a more accurate and granular way. Canada, including Alberta, took a 2 staged approach to legalization of recreational cannabis. Initially, in October 2018, flower-based products and oils were legalized for sale. One year later cannabis industry manufacturers were allowed to apply for licenses to produce and sell a wider variety of products, including Tetrahydrocannabinol (THC) containing edibles, drinks, and concentrates.   The authors noted that cannabis edibles were legalized in Canada in October 2019. Critically, however, these products did not become available on the market in most Canadian provinces, including Alberta, until January 2020.2 Previous...<p /> <p>Language: en</p>",
language="en",
issn="0031-4005",
doi="10.1542/peds.2022-057638A",
url="http://dx.doi.org/10.1542/peds.2022-057638A"
}